Phase 2 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be willing and able to give your consent to participate before any study activities begin.
- You must be at least 18 years old (male or female) at the time you sign the consent form.
- You must be generally healthy and able to carry out normal daily activities, with little or no limitation from your illness (confirm with trial site).
- Your cancer must have been confirmed through a tissue or cell sample, and you must not have received any treatment for it yet.
- You must be scheduled to receive a standard, FDA-approved chemotherapy treatment that includes cisplatin (a specific chemotherapy drug) at a total dose of at least 200 mg/m², for any solid tumour cancer that has not yet been treated.
Who may not be able to join:
- You have previously been treated with cisplatin for cancer.
- You are currently taking other medications that can damage hearing, and these cannot be safely stopped or swapped for a safer alternative.
- You are planned to have radiation therapy to the head or neck before, during, or within 3 months after finishing cisplatin treatment.
- You have had a serious allergic reaction to sulfite, sodium thiosulfate, or related ingredients in the past.
- Your blood sodium level is too high, or you have a significant imbalance in certain minerals in your blood (confirm with trial site).
- Your cisplatin treatment is planned to be given over more than 6 hours per infusion.
- You are pregnant, breastfeeding, or could become pregnant and are unwilling to use contraception during the treatment period.
- You are a male whose partner is pregnant, and you are unwilling to abstain from sex or use a condom during treatment.
- You are unlikely to be able to attend all required study visits or complete all study-related tasks.
- You have another significant health condition that, in your doctor's opinion, could put you at risk or interfere with the study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lisa Davis, PharmD, University of Arizona
Phone: 520-694-2873
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of intravenous STS to reduce hearing impairment associated with cisplatin
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.